Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of Seltorexant in Participants With Probable Alzheimer's Disease

ClinicalTrials.gov ID: NCT05307692

Public ClinicalTrials.gov record NCT05307692. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 6:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Investigate the Safety, Tolerability, and Clinical Efficacy of Seltorexant (JNJ-42847922) on Behavioral and Psychological Symptoms of Dementia in Patients With Probable Alzheimer's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to investigate the effect of seltorexant versus placebo on the sum of Agitation and Aggression domain scores (A plus A) of the Neuropsychiatric Inventory-Clinician rating (NPI-C) in participants with probable Alzheimer's Disease (AD) with clinically significant agitation/aggression.

Study identification

NCT ID
NCT05307692
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
88 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
55 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 18, 2022
Primary completion
Nov 9, 2023
Completion
Nov 9, 2023
Last update posted
Apr 26, 2025

2022 – 2023

United States locations

U.S. sites
25
U.S. states
11
U.S. cities
15
Facility City State ZIP Site status
Medical Advancement Center of Arizona Tempe Arizona 85283
Sunwise Clinical Research Lafayette California 94549
Luminous Clinical Research Homestead Florida 33030
Global Medical Institutes Miami Florida 33125
Office of Emilio Mantero-Atienza, MD Miami Florida 33135
Allied Biomedical Research Institute (ABRI), Inc Miami Florida 33155-4630
Quantix Research Miami Florida 33155
Entrust Clinical Research Miami Florida 33156
Florida International Research Center (FIRC) Miami Florida 33173
P&S Research, LLC Miami Florida 33175
IMIC Inc Miami Florida 33176
Biovision Medical Miami Florida 33184
South Florida Research Center Inc. Miami Springs Florida 33166
Intercoastal Medical Group Sarasota Florida 34239
Accel Clinical Research Seminole Florida 33777
Sonar Clinical Research Atlanta Georgia 30315
NeuroTrials Research Inc Atlanta Georgia 30328
Atlanta Center for Medical Research Atlanta Georgia 30331
Ochsner Medical Center New Orleans Louisiana 70121
Boston Clinical Trials Boston Massachusetts 02131
Richmond Behavioral Associates Staten Island New York 10312
Vanderbilt University Medical Center Nashville Tennessee 37232
Gill Neuroscience Cypress Texas 77429
Wasatch Clinical Research Salt Lake City Utah 84107
Memory Clinic Inc Bennington Vermont 05201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05307692, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 26, 2025 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05307692 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →